Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer.
Chen F, Ma K, Madajewski B, Zhuang L, Zhang L, Rickert K, Marelli M, Yoo B, Turker MZ, Overholtzer M, Quinn TP, Gonen M, Zanzonico P, Tuesca A, Bowen MA, Norton L, Subramony JA, Wiesner U, Bradbury MS.
Chen F, et al. Among authors: tuesca a.
Nat Commun. 2018 Oct 8;9(1):4141. doi: 10.1038/s41467-018-06271-5.
Nat Commun. 2018.
PMID: 30297810
Free PMC article.